Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $63.8000 (6.33%) ($57.5000 - $66.0000) on Fri. Feb. 13, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.52% (three month average) | RSI | 64 | Latest Price | $63.8000(6.33%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 0.8% a day on average for past five trading days. | Weekly Trend | CAPR advances 1.4% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) IVE(7%) PEJ(7%) SPY(7%) VT(7%) XLF(7%) | Factors Impacting CAPR price | CAPR will decline at least -3.26% in a week (0% probabilities). VIXM(-5%) TLT(-4%) SLV(-2%) SHY(-2%) GLD(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.26% (StdDev 6.52%) | Hourly BBV | 0 () | Intraday Trend | 1.3% | | | |
|
5 Day Moving Average | $61.4(3.91%) | 10 Day Moving Average | $61.32(4.04%) | 20 Day Moving Average | $55.81(14.32%) | To recent high | -2.7% | To recent low | 87.6% | Market Cap | $1.257b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |